169 related articles for article (PubMed ID: 26280620)
1. Drugging the Ral GTPase.
Yan C; Jones DN; Theodorescu D
Small GTPases; 2015; 6(3):157-9. PubMed ID: 26280620
[TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of small molecules that target the GTPase Ral.
Yan C; Liu D; Li L; Wempe MF; Guin S; Khanna M; Meier J; Hoffman B; Owens C; Wysoczynski CL; Nitz MD; Knabe WE; Ahmed M; Brautigan DL; Paschal BM; Schwartz MA; Jones DN; Ross D; Meroueh SO; Theodorescu D
Nature; 2014 Nov; 515(7527):443-7. PubMed ID: 25219851
[TBL] [Abstract][Full Text] [Related]
3. RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.
Yan C; Theodorescu D
Pharmacol Rev; 2018 Jan; 70(1):1-11. PubMed ID: 29196555
[TBL] [Abstract][Full Text] [Related]
4. The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.
Guin S; Theodorescu D
Acta Pharmacol Sin; 2015 Mar; 36(3):291-7. PubMed ID: 25557115
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Ral GTPases Using a Stapled Peptide Approach.
Thomas JC; Cooper JM; Clayton NS; Wang C; White MA; Abell C; Owen D; Mott HR
J Biol Chem; 2016 Aug; 291(35):18310-25. PubMed ID: 27334922
[TBL] [Abstract][Full Text] [Related]
6. Small molecules inhibit the RAS-like small GTPases RALA and RALB.
Cancer Discov; 2014 Nov; 4(11):1251. PubMed ID: 25367937
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases.
Bum-Erdene K; Liu D; Gonzalez-Gutierrez G; Ghozayel MK; Xu D; Meroueh SO
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7131-7139. PubMed ID: 32179690
[TBL] [Abstract][Full Text] [Related]
8. The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
Cooper JM; Bodemann BO; White MA
Enzymes; 2013; 34 Pt. B():137-56. PubMed ID: 25034103
[TBL] [Abstract][Full Text] [Related]
9. The RAL signaling network: Cancer and beyond.
Apken LH; Oeckinghaus A
Int Rev Cell Mol Biol; 2021; 361():21-105. PubMed ID: 34074494
[TBL] [Abstract][Full Text] [Related]
10. Therapy: GTPase Ral-a new tumour target.
Thoma C
Nat Rev Urol; 2014 Dec; 11(12):658. PubMed ID: 25266572
[No Abstract] [Full Text] [Related]
11. Re: Discovery and Characterization of Small Molecules that Target the GTPase Ral.
Atala A
J Urol; 2015 Jul; 194(1):259. PubMed ID: 26088252
[No Abstract] [Full Text] [Related]
12. Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases.
Hurd CA; Brear P; Revell J; Ross S; Mott HR; Owen D
J Biol Chem; 2021; 296():100101. PubMed ID: 33214225
[TBL] [Abstract][Full Text] [Related]
13. Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma.
Yoshimachi S; Shirakawa R; Cao M; Trinh DA; Gao P; Sakata N; Miyazaki K; Goto K; Miura T; Ariake K; Maeda S; Masuda K; Ishida M; Ohtsuka H; Unno M; Horiuchi H
Cancer Sci; 2021 Aug; 112(8):3064-3073. PubMed ID: 34009715
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.
Feldmann G; Mishra A; Hong SM; Bisht S; Strock CJ; Ball DW; Goggins M; Maitra A; Nelkin BD
Cancer Res; 2010 Jun; 70(11):4460-9. PubMed ID: 20484029
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide activates Rap1 and Ral in a Ras-independent manner.
Mittar D; Sehajpal PK; Lander HM
Biochem Biophys Res Commun; 2004 Sep; 322(1):203-9. PubMed ID: 15313192
[TBL] [Abstract][Full Text] [Related]
16. Targeting Ras signaling in AML: RALB is a small GTPase with big potential.
Pomeroy EJ; Eckfeldt CE
Small GTPases; 2020 Jan; 11(1):39-44. PubMed ID: 28682649
[TBL] [Abstract][Full Text] [Related]
17. Ral GTPases: crucial mediators of exocytosis and tumourigenesis.
Shirakawa R; Horiuchi H
J Biochem; 2015 May; 157(5):285-99. PubMed ID: 25796063
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of RalA and RalB in colorectal cancer.
Martin TD; Der CJ
Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
[TBL] [Abstract][Full Text] [Related]
19. Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.
Lu S; Jang H; Gu S; Zhang J; Nussinov R
Chem Soc Rev; 2016 Sep; 45(18):4929-52. PubMed ID: 27396271
[TBL] [Abstract][Full Text] [Related]
20. Ral overactivation in malignant peripheral nerve sheath tumors.
Bodempudi V; Yamoutpoor F; Pan W; Dudek AZ; Esfandyari T; Piedra M; Babovick-Vuksanovic D; Woo RA; Mautner VF; Kluwe L; Clapp DW; De Vries GH; Thomas SL; Kurtz A; Parada LF; Farassati F
Mol Cell Biol; 2009 Jul; 29(14):3964-74. PubMed ID: 19414599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]